Rett Syndrome clinical trials at UCSF

1 research study open to eligible people

Rett syndrome is a rare disorder that affects the brain's development. UCSF is part of a study called the Rett Syndrome Registry, which follows people with MECP2 mutations. This study aims to collect valuable data on Rett syndrome over time.

Showing trials for

  • Rett Syndrome Registry

    open to eligible people ages 0-99

    The Rett Syndrome Registry is a longitudinal observational study of individuals with MECP2 mutations and a diagnosis of Rett syndrome. Designed together with the IRSF Rett Syndrome Center of Excellence Network medical directors, this study collects data on the signs and symptoms of Rett syndrome as reported by the Rett syndrome experts and by the caregivers of individuals with Rett syndrome. This study will be used to develop consensus based guidelines for the care of your loved ones with Rett syndrome and to facilitate the development of better clinical trials and other aspects of the drug development path for Rett syndrome.

    Oakland, California and other locations

Last updated: